OCRF News

First Annual T.E.A.L. Walk for Ovarian Cancer Research
09/12/2009


The first annual T.E.A.L. (Tell Every Amazing Lady) Walk will be held on Saturday, September 12 in Brooklyn's Prospect Park.  Proceeds will benefit Ovarian Cancer Research Fund.

The non-competitive 5K event, organized by the not-for-profit organization Tell Every Amazing Lady About Ovarian Cancer, is the first ovarian cancer-specific research walk in the city.  Co-founders Louisa McGregor and Pamela Esposito chose to create the walk because the cause is one close to their hearts.  Louisa is an ovarian cancer survivor dedicated to spreading awareness of the disease.  Through the walk, she hopes to provide women with the tools they need to educate themselves, while raising money to find a method of early detection.

Prior to organizing the event, Louisa appeared on the NBC Today Show and Channel 12 news to promote awareness, as well as numerous public service announcements, including some for Stand Up To Cancer and Gilda's Club NYC. 

The walk begins at 10:00 a.m. at the Bartel Pritchard Square Entrance of Prospect Park.  In addition to the walk itself, there will be educational booths and fun activities for the entire family to enjoy.  Pariticipants will include ovarian cancer survivors, caregivers, families and friends, all coming together for the cause.

Spread the word, form a team, bring your family, and help make the first annual T.E.A.L. Walk a success!

To register, visit the T.E.A.L. Walk website. 
















 
 

The five-year survival rate for ovarian cancer has increased by only 8% in the last 30 years.
We are at a critical crossroads for supporting research into unlocking the mysteries of ovarian cancer. You can make a difference by supporting the research of the Ovarian Cancer Research Fund.

Help us find a cure for ovarian cancer. Donate online and make a difference.




Every day throughout September, OCRF will present one new fact about ovarian cancer.

1. In 1809 Dr. Ephraim McDowell of Danville, Kentucky became the first surgeon in the world to successfully remove an ovarian tumor. The patient survived the surgery and went on to live a long life.

2. Some researchers are investigating evidence for the premise that an effective therapeutic vaccine against ovarian cancer is useful not only for inducing remission of the disease but also for preventing disease relapse. (Journal of Hematology & Oncology 2010, 3:7, Liu, B., Nash, J., Runowicz, C., Swede, H., Stevens, R., and Li, Z.)

3. A woman's lifetime risk of developing ovarian cancer is 1 in 71, with most cases developing post-menopause.

4. The symptoms of ovarian cancer, such as bloating, pelvic or abdominal pain, feeling of fullness or urinary issues, can be subtle but are often present early.

5. Approximately 22,000 women in the United States will be diagnosed with ovarian cancer this year.

6. Approximately 37% of OCRF grantees have been women; 43% are racial or ethnic minorities.